Results 211 to 220 of about 11,713 (255)

Application of CRISPR/Cas9 technology in the modeling of Gaucher disorder. [PDF]

Biochem Biophys Rep
Reyhani-Ardabili M, Fathi M, Ghafouri-Fard S.   +2 more
europepmc   +1 more source

Study of Adult and Pediatric Spanish Patients with Cryptogenic Splenomegaly and Splenectomy. [PDF]

Diseases
Morado Arias M, Villarrubia Espinosa J, Vitoria Miñana I, Calderón Sandubete E, Quintero V, Torralba-Cabeza MÁ.   +5 more
europepmc   +1 more source

Author response: Extracellular vesicle-mediated release of bis(monoacylglycerol)phosphate is regulated by LRRK2 and Glucocerebrosidase activity

Elsa Meneses‐Salas, Moisés Castellá, Marianna Arnold, F. Hsieh, Rubén Fernández‐Santiago, Mario Ezquerra, Alícia Garrido, María‐José Martí, Carlos Enrich, Suzanne R. Pfeffer, Kalpana Merchant, Albert Lu   +11 more
openalex   +1 more source

Synaptic and cognitive impairment associated with L444P heterozygous glucocerebrosidase mutation. [PDF]

Brain
Lado W, Ham A, Li H, Zhang H, Chang AY, Sardi SP, Alcalay RN, Arancio O, Przedborski S, Tang G.   +9 more
europepmc   +1 more source

Lewy pathology formation in patient-derived GBA1 Parkinson's disease midbrain organoids. [PDF]

Brain
Frattini E, Faustini G, Lopez G, Carsana EV, Tosi M, Trezzi I, Magni M, Soldà G, Straniero L, Facchi D, Samarani M, Martá-Ariza M, De Luca CMG, Vezzoli E, Pittaro A, Stepanyan A, Silipigni R, Rosety I, Schwamborn JC, Sardi SP, Moda F, Corti S, Comi GP, Blandini F, Tritsch NX, Bortolozzi M, Ferrero S, Cribiù FM, Wisniewski T, Asselta R, Aureli M, Bellucci A, Di Fonzo A.   +32 more
europepmc   +1 more source

Investigational Gene Therapies for Parkinson's Disease. [PDF]

CNS Drugs
Phielipp N, Henchcliffe C.
europepmc   +1 more source

New Antibodies to Advance Glucocerebrosidase Research

Journal of Parkinson’s Disease
openaire   +2 more sources

Non-neuronopathic Gaucher disease (Type I) in an elderly female: a case report. [PDF]

Ann Med Surg (Lond)
Bohara S, Bhattarai S, Khadka M, Ghimire D, Karki S, Poudel N, Aryal G, Dhakal SS.   +7 more
europepmc   +1 more source

Developing nanobodies as allosteric molecular chaperones of glucocerebrosidase function. [PDF]

Nat Commun
Dal Maso T, Sinisgalli C, Zilio G, Franzin E, Tessari I, Pardon E, Steyaert J, Ballet S, Greggio E, Versées W, Plotegher N.   +10 more
europepmc   +1 more source